These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 27977724

  • 21. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
    Niederberger V, Pauli G, Grönlund H, Fröschl R, Rumpold H, Kraft D, Valenta R, Spitzauer S.
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
    [Abstract] [Full Text] [Related]

  • 22. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
    van Hage-Hamsten M, Kronqvist M, Zetterström O, Johansson E, Niederberger V, Vrtala S, Grönlund H, Grönneberg R, Valenta R.
    J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
    [Abstract] [Full Text] [Related]

  • 23. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
    Gieras A, Cejka P, Blatt K, Focke-Tejkl M, Linhart B, Flicker S, Stoecklinger A, Marth K, Drescher A, Thalhamer J, Valent P, Majdic O, Valenta R.
    J Immunol; 2011 May 01; 186(9):5333-44. PubMed ID: 21451110
    [Abstract] [Full Text] [Related]

  • 24. Natural immunity to Ascaris lumbricoides associated with immunoglobulin E antibody to ABA-1 allergen and inflammation indicators in children.
    McSharry C, Xia Y, Holland CV, Kennedy MW.
    Infect Immun; 1999 Feb 01; 67(2):484-9. PubMed ID: 9916049
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
    Kaul S, Scheurer S, Danz N, Schicktanz S, Vieths S, Hoffmann A.
    J Allergy Clin Immunol; 2003 Jun 01; 111(6):1262-8. PubMed ID: 12789227
    [Abstract] [Full Text] [Related]

  • 26. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R, Stepanoska T, Ferreira F, Valenta R, Vrtala S, Thalhamer J, Hartl A.
    Eur J Immunol; 2003 Jun 01; 33(6):1667-76. PubMed ID: 12778485
    [Abstract] [Full Text] [Related]

  • 27. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
    Hofmann C, Scheurer S, Rost K, Graulich E, Jamin A, Foetisch K, Saloga J, Vieths S, Steinbrink K, Adler HS.
    J Allergy Clin Immunol; 2013 May 01; 131(5):1384-92.e6. PubMed ID: 23246018
    [Abstract] [Full Text] [Related]

  • 28. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
    Vrtala S, Mayer P, Ferreira F, Susani M, Sehon AH, Kraft D, Valenta R.
    J Allergy Clin Immunol; 1996 Nov 01; 98(5 Pt 1):913-21. PubMed ID: 8939154
    [Abstract] [Full Text] [Related]

  • 29. Vaccination for birch pollen allergy. Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1.
    Svenson M, Jacobi HH, Bødtger U, Poulsen LK, Rieneck K, Bendtzen K.
    Mol Immunol; 2003 Jan 01; 39(10):603-12. PubMed ID: 12431394
    [Abstract] [Full Text] [Related]

  • 30. Enlarging the toolbox for allergen epitope definition with an allergen-type model protein.
    Berkner H, Seutter von Loetzen C, Hartl M, Randow S, Gubesch M, Vogel L, Husslik F, Reuter A, Lidholm J, Ballmer-Weber B, Vieths S, Rösch P, Schiller D.
    PLoS One; 2014 Jan 01; 9(10):e111691. PubMed ID: 25356997
    [Abstract] [Full Text] [Related]

  • 31. Parasite allergens.
    Caraballo L, Coronado S.
    Mol Immunol; 2018 Aug 01; 100():113-119. PubMed ID: 29588070
    [Abstract] [Full Text] [Related]

  • 32. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B.
    J Allergy Clin Immunol; 2013 Jan 01; 131(1):94-102. PubMed ID: 22921871
    [Abstract] [Full Text] [Related]

  • 33. The allergen profile of beech and oak pollen.
    Egger C, Focke M, Bircher AJ, Scherer K, Mothes-Luksch N, Horak F, Valenta R.
    Clin Exp Allergy; 2008 Oct 01; 38(10):1688-96. PubMed ID: 18754759
    [Abstract] [Full Text] [Related]

  • 34. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy.
    Ferreira F, Ebner C, Kramer B, Casari G, Briza P, Kungl AJ, Grimm R, Jahn-Schmid B, Breiteneder H, Kraft D, Breitenbach M, Rheinberger HJ, Scheiner O.
    FASEB J; 1998 Feb 01; 12(2):231-42. PubMed ID: 9472988
    [Abstract] [Full Text] [Related]

  • 35. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study.
    Eckl-Dorna J, Fröschl R, Lupinek C, Kiss R, Gattinger P, Marth K, Campana R, Mittermann I, Blatt K, Valent P, Selb R, Mayer A, Gangl K, Steiner I, Gamper J, Perkmann T, Zieglmayer P, Gevaert P, Valenta R, Niederberger V.
    Allergy; 2018 May 01; 73(5):1003-1012. PubMed ID: 29083477
    [Abstract] [Full Text] [Related]

  • 36. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
    Karamloo F, Schmitz N, Scheurer S, Foetisch K, Hoffmann A, Haustein D, Vieths S.
    J Allergy Clin Immunol; 1999 Nov 01; 104(5):991-9. PubMed ID: 10550744
    [Abstract] [Full Text] [Related]

  • 37. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens.
    Canis M, Gröger M, Becker S, Klemens C, Kramer MF.
    Am J Rhinol Allergy; 2011 Nov 01; 25(1):36-9. PubMed ID: 21711974
    [Abstract] [Full Text] [Related]

  • 38. Can serum white birch (Betula verrucosa) pollen antigen (Bet v 1) immunoglobulin E measurement distinguish between sensitization and allergy?
    Ciprandi G, Comite P, Ferrero F, Minale P, Voltolini S, Bignardi D, Fontana V, Bruzzone M, Troise C, Mussap M.
    Int Forum Allergy Rhinol; 2015 Dec 01; 5(12):1151-5. PubMed ID: 26250401
    [Abstract] [Full Text] [Related]

  • 39. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
    Mari A, Wallner M, Ferreira F.
    Clin Exp Allergy; 2003 Oct 01; 33(10):1419-28. PubMed ID: 14519150
    [Abstract] [Full Text] [Related]

  • 40. Detection of Bet v1, Bet v2 and Bet v4 specific IgE antibodies in the sera of children and adult patients allergic to birch pollen: evaluation of different IgE reactivity profiles depending on age and local sensitization.
    Sekerková A, Poláčková M.
    Int Arch Allergy Immunol; 2011 Oct 01; 154(4):278-85. PubMed ID: 20962532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.